Disc Medicine (IRON) Depreciation and Depletion (2020 - 2021)

Disc Medicine's (IRON) quarterly Depreciation and Depletion came in at $46000.0 in Q4 2021, down 47.13% year-on-year from $87000.0 in Q4 2020, and down 20.69% on a QoQ basis from $58000.0 in Q3 2021.

Disc Medicine (IRON) Depreciation and Depletion (2020 - 2021) Analysis & Trends

Disc Medicine (IRON) has 2 years of Depreciation and Depletion data on file, last reported at $46000.0 in Q4 2021.

  • On a quarterly basis, Depreciation and Depletion fell 47.13% year-over-year to $46000.0 in Q4 2021; TTM through Sep 2022 was $46000.0, a 83.09% decrease from a year earlier, with the FY2024 full-year figure at $200000.0, up 100.0% from the prior year.
  • Depreciation and Depletion for Q4 2021 stood at $46000.0, down from $58000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for IRON reached as high as $87000.0 in Q4 2020 and fell as low as $46000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Oculis Holding AG 66,801.52 Bn 66,801.23 Bn - 196,658.72
2 Nanobiotix 1,916.61 Bn 1,916.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.65 Bn 466.85 Bn 1.35 Bn 39.39 Mn
5 Vertex Pharmaceuticals 121.94 Bn 114.69 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.85 Bn 61.09 Bn 3.31 Bn -
7 Belite Bio 63.06 Bn 63.06 Bn - -
8 Argenx Se 55.74 Bn 50.56 Bn 1.41 Bn -
9 Revolution Medicines 37.48 Bn 37.48 Bn - 2.20 Mn
10 Disc Medicine 2.89 Bn 2.89 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 46,000.00
Dec 31, 2021 46,000.00
Sep 30, 2021 58,000.00
Sep 30, 2021 58,000.00
Jun 30, 2021 62,000.00
Jun 30, 2021 62,000.00
Mar 31, 2021 65,000.00
Mar 31, 2021 65,000.00
Dec 31, 2020 87,000.00
Dec 31, 2020 87,000.00
Sep 30, 2020 80,000.00
Sep 30, 2020 80,000.00
Jun 30, 2020 78,000.00
Jun 30, 2020 78,000.00
Mar 31, 2020 77,000.00
Mar 31, 2020 77,000.00